On demand
Claude for Life Sciences: Accelerating Discovery from Hypothesis to Breakthrough
Join us for an exclusive look at how leading pharmaceutical companies and research institutions are transforming their R&D operations with Claude. See live demonstrations of hypothesis generation, protocol optimization, and bioinformatics analysis capabilities, as well as hear directly from life sciences industry leaders on how they're driving AI transformation at scale.
Whether you're evaluating AI for your research teams or scaling existing deployments, you'll leave with practical insights on achieving measurable outcomes in drug discovery, experimental design, literature analysis, and research efficiency.
Featured speakers
Ashu Singhal
Co-Founder and President @ Benchling
Cyril Zaidan
AI Product Lead @ Sanofi
Sarah Nam
VP, AI Strategy and Partnerships @ AbbVie
Waheed Jowiya
Digitalisation Strategy Director @ Novo Nordisk
Scott Ogden
Head of AI Labs @ Genmab
Jonah Cool
Head of Life Sciences Partnerships, Anthropic
Eric Kauderer-Abrams
Head of Life Sciences @ Anthropic
What you’ll learn
Gain firsthand perspectives from Anthropic's leadership on the future of AI in life sciences research
Learn from executive viewpoints across leading pharmaceutical companies and Anthropic partners as they share their AI adoption experiences
See Claude's specialized life sciences capabilities in action, addressing actual challenges faced by research teams across the industry